Sino Medical Sciences Technology In (SHG:688108) — Stock Price
Sino Medical Sciences Technology In (SHG:688108) is currently trading at CN¥18.66 CNY, up 6.63% today. Over the past 52 weeks, shares have ranged between CN¥15.18 and CN¥41.48. This page tracks Sino Medical Sciences Technology In's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Sino Medical Sciences Technology In.
Sino Medical Sciences Technology In (688108) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Sino Medical Sciences Technology In's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sino Medical Sciences Technology In Income Statement — Revenue, Profit & Earnings by Year
Sino Medical Sciences Technology In's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥525.41 Million | CN¥458.74 Million | CN¥343.26 Million | CN¥192.85 Million | CN¥194.36 Million |
| Cost of Revenue | CN¥176.98 Million | CN¥192.64 Million | CN¥145.64 Million | CN¥85.64 Million | CN¥60.25 Million |
| Gross Profit | CN¥525.41 Million | CN¥266.10 Million | CN¥197.62 Million | CN¥107.21 Million | CN¥134.11 Million |
| Research & Development | CN¥122.57 Million | CN¥140.56 Million | CN¥114.10 Million | CN¥152.80 Million | CN¥148.93 Million |
| SG&A | CN¥55.96 Million | CN¥89.11 Million | CN¥94.26 Million | CN¥119.08 Million | CN¥91.50 Million |
| Total Operating Expenses | CN¥458.60 Million | CN¥283.06 Million | CN¥267.04 Million | CN¥326.39 Million | CN¥297.38 Million |
| Operating Income | CN¥66.80 Million | CN¥-16.97 Million | CN¥-69.42 Million | CN¥-219.18 Million | CN¥-163.28 Million |
| EBITDA | CN¥133.04 Million | CN¥53.27 Million | CN¥-13.01 Million | CN¥-168.43 Million | CN¥-108.50 Million |
| EBIT | CN¥68.45 Million | CN¥-11.33 Million | CN¥-63.93 Million | CN¥-218.79 Million | CN¥-160.74 Million |
| Interest Expense | CN¥5.05 Million | CN¥5.83 Million | CN¥3.93 Million | CN¥2.55 Million | CN¥2.36 Million |
| Income Before Tax | CN¥68.45 Million | CN¥-17.16 Million | CN¥-67.86 Million | CN¥-221.34 Million | CN¥-163.10 Million |
| Income Tax Expense | CN¥21.16 Million | CN¥-13.27 Million | CN¥-24.46 Million | CN¥-48.03 Million | CN¥-31.80 Million |
| Net Income | CN¥47.29 Million | CN¥1.50 Million | CN¥-39.63 Million | CN¥-162.38 Million | CN¥-130.77 Million |
Sino Medical Sciences Technology In Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sino Medical Sciences Technology In's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥1.35 Billion | CN¥1.30 Billion | CN¥1.19 Billion | CN¥1.07 Billion | CN¥1.10 Billion |
| Total Current Assets | CN¥520.39 Million | CN¥403.39 Million | CN¥344.18 Million | CN¥354.90 Million | CN¥430.80 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CN¥25.14 Million | CN¥18.90 Million | CN¥27.74 Million | CN¥20.28 Million | CN¥12.00 Million |
| Inventory | CN¥88.79 Million | CN¥89.51 Million | CN¥118.22 Million | CN¥98.13 Million | CN¥84.88 Million |
| Property, Plant & Equipment | — | — | — | CN¥176.77 Million | CN¥172.58 Million |
| Goodwill | CN¥46.22 Million | CN¥46.22 Million | — | — | — |
| Total Liabilities | CN¥-931.81 Million | CN¥402.22 Million | CN¥324.17 Million | CN¥180.13 Million | CN¥157.92 Million |
| Total Current Liabilities | CN¥333.75 Million | CN¥192.02 Million | CN¥151.27 Million | CN¥132.18 Million | CN¥92.56 Million |
| Long-term Debt | — | CN¥54.80 Million | CN¥50.30 Million | — | — |
| Net Debt | — | CN¥-164.84 Million | CN¥-44.15 Million | CN¥-145.11 Million | CN¥-243.48 Million |
| Total Stockholder Equity | CN¥931.81 Million | CN¥866.89 Million | CN¥819.96 Million | CN¥847.08 Million | CN¥927.84 Million |
| Retained Earnings | CN¥-193.53 Million | CN¥-233.23 Million | CN¥-234.73 Million | CN¥-195.10 Million | CN¥-42.23 Million |
Sino Medical Sciences Technology In Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sino Medical Sciences Technology In generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥161.87 Million | CN¥131.24 Million | CN¥56.84 Million | CN¥-111.31 Million | CN¥-60.13 Million |
| Capital Expenditures | CN¥45.80 Million | CN¥70.02 Million | CN¥67.67 Million | CN¥110.76 Million | CN¥158.45 Million |
| Free Cash Flow | CN¥116.07 Million | CN¥61.22 Million | CN¥-10.83 Million | CN¥-222.07 Million | CN¥-218.58 Million |
| Investing Cash Flow | — | CN¥-89.46 Million | CN¥-193.04 Million | CN¥-88.93 Million | CN¥-186.59 Million |
| Financing Cash Flow | — | CN¥61.47 Million | CN¥122.32 Million | CN¥116.86 Million | CN¥-9.43 Million |
| Dividends Paid | CN¥4.19 Million | CN¥4.11 Million | CN¥2.01 Million | CN¥940.06K | CN¥29.44K |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥75.40 Million | CN¥78.16 Million | CN¥62.81 Million | CN¥63.17 Million | CN¥65.41 Million |
| Change in Cash | CN¥-291.67 Million | CN¥103.03 Million | CN¥-14.78 Million | CN¥-84.33 Million | CN¥-256.91 Million |
Sino Medical Sciences Technology In Earnings History — EPS Actual vs. Analyst Estimates
Track Sino Medical Sciences Technology In's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 26, 2023 | -0.04 | — | — |
| Dec 31, 2022 | -0.13 | — | — |
| Sep 30, 2022 | -0.09 | — | — |
| Jun 30, 2022 | -0.10 | — | — |
| Mar 31, 2022 | -0.07 | — | — |
| Feb 25, 2022 | -0.05 | — | — |
| Oct 28, 2021 | -0.07 | — | — |
| Aug 24, 2021 | -0.10 | — | — |